258 related articles for article (PubMed ID: 37483588)
21. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
[TBL] [Abstract][Full Text] [Related]
22. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma.
Lee LT; Wong YK; Hsiao HY; Wang YW; Chan MY; Chang KW
Int J Oral Maxillofac Surg; 2018 Jun; 47(6):699-707. PubMed ID: 29174861
[TBL] [Abstract][Full Text] [Related]
24. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
[TBL] [Abstract][Full Text] [Related]
25. Identification of salivary autoantibodies as biomarkers of oral cancer with immunoglobulin A enrichment combined with affinity mass spectrometry.
Chu HW; Chang KP; Yen WC; Liu HP; Chan XY; Liu CR; Hung CM; Wu CC
Proteomics; 2023 May; 23(9):e2200321. PubMed ID: 36625099
[TBL] [Abstract][Full Text] [Related]
26. Salivary auto-antibodies as noninvasive diagnostic markers of oral cavity squamous cell carcinoma.
Wu CC; Chang YT; Chang KP; Liu YL; Liu HP; Lee IL; Yu JS; Chiang WF
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1569-78. PubMed ID: 24859869
[TBL] [Abstract][Full Text] [Related]
27. Oral carcinogenesis and non-invasive biomarkers for the diagnosis of oral squamous cell carcinoma.
Khan S; Alamgir MM
J Pak Med Assoc; 2024 Feb; 74(2):370-373. PubMed ID: 38419239
[TBL] [Abstract][Full Text] [Related]
28. Increased Expression of Tissue/Salivary Transgelin mRNA Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma (OSCC).
Bu J; Bu X; Liu B; Chen F; Chen P
Med Sci Monit; 2015 Aug; 21():2275-81. PubMed ID: 26242444
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic Accuracy of Salivary Biomarkers in Detecting Early Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Shaw AK; Garcha V; Shetty V; Vinay V; Bhor K; Ambildhok K; Karande P
Asian Pac J Cancer Prev; 2022 May; 23(5):1483-1495. PubMed ID: 35633529
[TBL] [Abstract][Full Text] [Related]
30. The Clinical Potential of Oral Microbiota as a Screening Tool for Oral Squamous Cell Carcinomas.
Zhou X; Hao Y; Peng X; Li B; Han Q; Ren B; Li M; Li L; Li Y; Cheng G; Li J; Ma Y; Zhou X; Cheng L
Front Cell Infect Microbiol; 2021; 11():728933. PubMed ID: 34485181
[TBL] [Abstract][Full Text] [Related]
31. Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation.
Rai AK; Panda M; Das AK; Rahman T; Das R; Das K; Sarma A; Kataki AC; Chattopadhyay I
Arch Microbiol; 2021 Jan; 203(1):137-152. PubMed ID: 32783067
[TBL] [Abstract][Full Text] [Related]
32. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.
Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA
BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690
[TBL] [Abstract][Full Text] [Related]
33. Detection of survivin, carcinoembryonic antigen and ErbB2 level in oral squamous cell carcinoma patients.
Li SX; Yang YQ; Jin LJ; Cai ZG; Sun Z
Cancer Biomark; 2016; 17(4):377-382. PubMed ID: 27662323
[TBL] [Abstract][Full Text] [Related]
34. PD-L1 in oral squamous cell carcinoma: A key biomarker from the laboratory to the bedside.
Nocini R; Vianini M; Girolami I; Calabrese L; Scarpa A; Martini M; Morbini P; Marletta S; Brunelli M; Molteni G; Parwani A; Pantanowitz L; Eccher A
Clin Exp Dent Res; 2022 Jun; 8(3):690-698. PubMed ID: 35593124
[TBL] [Abstract][Full Text] [Related]
35. Comparison of PD-L1 Expression in Oral Squamous Cell Carcinoma and Premalignant Lesions of Oral Cavity.
Saeed S; Rauf F; Iqbal F; Khan AS; Khan AH; Alamgeer R
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4039-4045. PubMed ID: 36579984
[TBL] [Abstract][Full Text] [Related]
36. Validation of Salivary Markers, IL-1β, IL-8 and Lgals3bp for Detection of Oral Squamous Cell Carcinoma in an Indian Population.
Singh P; Verma JK; Singh JK
Sci Rep; 2020 Apr; 10(1):7365. PubMed ID: 32355279
[TBL] [Abstract][Full Text] [Related]
37. Estimation of Salivary 8-Hydroxydeoxyguanosine (8-OHdG) as a Potential Biomarker in Assessing Progression towards Malignancy: A Case-Control Study.
Nandakumar A; Nataraj P; James A; Krishnan R; K M M
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2325-2329. PubMed ID: 32856861
[TBL] [Abstract][Full Text] [Related]
38. Role of salivary biomarkers in early detection of oral squamous cell carcinoma.
Awasthi N
Indian J Pathol Microbiol; 2017; 60(4):464-468. PubMed ID: 29323056
[TBL] [Abstract][Full Text] [Related]
39. B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma.
Wu L; Deng WW; Yu GT; Mao L; Bu LL; Ma SR; Liu B; Zhang WF; Sun ZJ
Cancer Immunol Immunother; 2016 Sep; 65(9):1035-45. PubMed ID: 27383830
[TBL] [Abstract][Full Text] [Related]
40. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
